New Delhi, Oct. 13 -- India has initiated an anti-dumping investigation into imports of Penicillin G and its salts from China following a complaint by domestic manufacturer Lyfius Pharma, which alleged that the imports were causing material retardation to the domestic industry.

The Directorate General of Trade Remedies (DGTR), under the Ministry of Commerce and Industry, said there was sufficient prima facie evidence that the product was being dumped in the Indian market. Lyfius Pharma has sought the imposition of anti-dumping duties.

The investigation covers Penicillin G in various forms, grades and concentrations, including its salt forms, in solid and liquid forms, reported The Hindu.

Domestic Production Under Pressure

Lyfius Pharm...